Wistar’s Chi Van Dang, M.D., Ph.D., Named Editor-in-Chief of AACR Journal Cancer Research
PHILADELPHIA—(Jan. 11, 2018)— The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, is pleased to announce Wistar professor Chi Van Dang, M.D., Ph.D., has been appointed Editor-in-Chief of Cancer Research, a journal of the American Association for Cancer Research (AACR). Published under different titles in its early years, Cancer Research was the first English-language journal to be published in the field of oncology.
Dang is a professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute and the scientific director of the Ludwig Institute for Cancer Research in New York. Dang officially began his term as editor-in-chief of Cancer Research on Jan. 1, and his inaugural editorial can be found here.
“I am delighted to assume responsibility for this influential journal at a time when cancer research is providing hope that allows us to begin to use the word ‘cure’ without trepidation,” Dang said. “Together with the newly assembled editorial board, I look forward to promoting major scientific findings that embrace innovative research paradigms and team science.”
Dang has authored more than 200 scientific and medical articles and book chapters as well as books. He is the recipient of numerous honors, including appointment to the Blue-Ribbon Panel of Vice President Joe Biden’s National Cancer Moonshot Initiative. Dang is currently chair of the National Cancer Institute Board of Scientific Advisors. He is a fellow to the American Academy of Arts & Sciences and is a member of the National Academy of Medicine, American Society for Clinical Investigation, and The Association of American Physicians.
Prior to his appointments at Wistar and the Ludwig Institute for Cancer Research, Dang was the Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, M.D., Abramson Cancer Center Director’s Professor. Dang graduated with a B.S. in chemistry from the University of Michigan, a Ph.D. in chemistry from Georgetown University and a medical degree from Johns Hopkins University School of Medicine.
The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has held the prestigious Cancer Center designation from the National Cancer Institute since 1972. The Institute works actively to ensure that research advances move from the laboratory to the clinic as quickly as possible. wistar.org.